HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Continuous transcutaneous pO2-criterion of newborn condition, depending on obstetric circumstances (author's transl)].

Abstract
Arterial pO2 was transcutaneously recorded under standardized conditions from 55 newborns, right after birth. Two values, pO2 with air breathing 30 minutes after birth and the pO2 peak following oxygen breathing, were compared, with reference being made to their dependence on obstetric conditions. Significant deterioration of oxygen supply, as compared to a control group, was recordable from high-risk births, infants delivered from breech presentation by the vaginal route, and from newborns with neonatal acidosis. Oxygen supply to surgically delivered high-risk infants came very close to that recorded from normally born children, while that established from infants born by caesarean section was in agreement with values of hyperoxia. High-continuity measurement of pO2, immediately after childbirth, can be used as a criterion by which to assess obstetric performance. It can be also an objective parameter for an assessment of postpartum adaptation, and a tool by which to figure out endangered newborns.
AuthorsH Bellée, V Schönjahn
JournalZentralblatt fur Gynakologie (Zentralbl Gynakol) Vol. 102 Issue 20 Pg. 1190-3 ( 1980) ISSN: 0044-4197 [Print] Germany
Vernacular TitleKontinuierlicher transkutaner pO2 als Kriterium für den Zustand des Neugeborenen in Abhängigkeit von geburtshilflichen Umständen.
PMID7211021 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Oxygen
Topics
  • Cesarean Section
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases (blood)
  • Obstetric Labor Complications (blood)
  • Oxygen (blood)
  • Pregnancy
  • Pregnancy Complications (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: